Press Releases | Medtronic

Month Year

Email alerts

Oct 26, 2016

Medtronic Announces FDA Approval of New Recaptureable TAVR System Available for Severe Aortic Stenosis Patients with Large Anatomies

Launch of 34 mm Self-Expanding Evolut R Device Expands TAVR Treatment to Patients Who Could Not be Treated Previously

DUBLIN - Oct. 26, 2016 - Medtronic plc (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the CoreValve(TM) Evolut(TM) R 34 mm valve-the largest...
Oct 24, 2016

MiniMed® Connect Mobile Accessory for Android Now Available from Medtronic

MiniMed Connect Mobile Accessory Provides Easier and Better Access to Pump and CGM Data, Helping Optimize Therapy for Improved Glycemic Patterns

DUBLIN - October 24, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. commercial availability of the Android(TM) operating system version of the...
Oct 24, 2016

Medtronic Receives FDA Clearance of New Lower Profile HawkOne 6F Directional Atherectomy System

New Technology Expands Treatment Options for Patients with Peripheral Artery Disease Both Above and Below the Knee

DUBLIN - Oct. 24, 2016 - Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the HawkOne(TM) Directional Atherectomy System in a new size for...
Oct 21, 2016

Medtronic to Webcast Investor and Analyst Briefings on October 26, 2016 and October 30, 2016

DUBLIN - Oct. 21, 2016 - Medtronic plc (NYSE:MDT) today announced the company will webcast investor and analyst briefings at two upcoming medical conferences. Medtronic will host a webcast to...
Oct 14, 2016

Medtronic Announces Voluntary Recall of Its Pipeline(TM) Embolization Device, Alligator(TM) Retrieval Device, X-Celerator(TM) Hydrophilic Guidewire, Ultraflow(TM) and Marathon(TM) Flow Directed Micro Catheters

DUBLIN - Oct. 14, 2016 - Medtronic plc (NYSE: MDT) today announced that it has notified customers of a voluntary recall of certain lots of its Pipeline(TM) embolization device, Alligator(TM)...
Oct 13, 2016

FIRE AND ICE Analysis: Lower Healthcare System Costs with Medtronic Cryoballoon

Late Breaking Clinical Trial Demonstrates Favorable Health Economics and Positive Clinical Outcomes for AF Patients

DUBLIN AND SEOUL, REPUBLIC OF KOREA - Oct. 13, 2016 - Medtronic plc (NYSE:MDT) today unveiled new health economic analysis data from the FIRE AND ICE trial that favor cryoballoon catheter ablation...
Oct 13, 2016

Medtronic Cardiac Devices Gain FDA Approval to Enable Patient Access to the Most Advanced Diagnostic Imaging

Patients with SureScan® Pacemakers, ICDs and CRT-Ds Now Can Receive 3 Tesla MRI Scans

DUBLIN - Oct. 13, 2016 - Medtronic plc (NYSE:MDT) is the first company to receive U.S. Food and Drug Administration (FDA) approval for its suite of cardiac rhythm and heart failure devices and...
Oct 3, 2016

Medtronic Avalus(TM) Surgical Aortic Valve Shows Positive Outcomes in One-Year Clinical Trial Results

Presented at EACTS, First Data of New Pericardial Heart Valve Finds High Survival and Excellent Hemodynamics

DUBLIN and BARCELONA - Oct. 3, 2016 - Medtronic plc (NYSE: MDT) today announced positive clinical data for its investigational Avalus(TM) pericardial aortic surgical valve, intended for the...
Sep 30, 2016

FDA Classifies Two Field Actions Related to HeartWare HVAD System as Class 1 Recalls

DUBLIN - Sept. 30, 2016 - Medtronic plc (NYSE:MDT) announced today that two previously communicated global voluntary recalls related to the HeartWare International (HeartWare) HVAD® System have...
Sep 28, 2016

Medtronic Receives FDA Clearance of TrailBlazer Angled Peripheral Support Catheter

TrailBlazer Angled Support Catheter Broadens Medtronic's Leading Peripheral Options Adding Full Spectrum of Angled Resources to Meet Provider Needs

DUBLIN - September 28, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) has cleared the TrailBlazer(TM) angled support catheter for use in the...

Show per page